Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
The MSL Role - Big Pharma Vs. Small Biotech
Summary
In this episode, Sarah Ussery joins to discuss her career journey and the distinctions between working in big pharma versus small biotech companies. Sarah provides an overview of both environments, highlighting the evolution of the MSL role and the responsibilities unique to each. She explores growth opportunities and the job market for both sectors, while addressing the challenges and cultural differences encountered in each setting. The conversation includes advice for MSLs navigating their careers in 2024, with insights on resume building and choosing between large pharma and small biotech. The episode concludes with closing remarks and a call to action.
My guest today is Sarah Ussery, Medical Affairs Leader who discusses the differences in MSL function between large pharma and small biotech.
Sarah shares….
👉 What is considered Large Pharma VS Small Biotech
👉 How do MSL responsibilities differ by size of company
👉 How are MSLs evaluated differently by different companies
👉 How do the frustrations differ for MSLs in different size companies
👉 What are the cultural differences between different size companies
MSL role differences, large pharma vs small biotech, career advice for MSLs, MSL job market 2024, cultural differences in pharma
Related Topics
You May Also Like
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO
Transforming oncology: Five frontiers driving progress in cancer care
Article
iNIZIO
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis